Karmali, R., Morschhauser, F., Izutsu, K., Palomba, L., Ardeshna, K., Hill, B., Kamdar, M., Schuster, S. J., Pinto, A., Dahiya, S., Bar, M., Strocchia, M., Kumar, J., Abramson, J. (2025). Patient-reported outcomes (PROs) with lisocabtagene maraleucel (liso-cel) in patients with third line or later (3L+) R/R MZL from the Phase 2 TRANSCEND FL study. Blood. https://doi.org/10.1182/blood-2025-709